• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[红细胞增多症]

[The polycythemias].

作者信息

Clément F

出版信息

Schweiz Med Wochenschr. 1981 Aug 15;111(33):1196-201.

PMID:7280628
Abstract

The primary polycythemias result from malignant proliferation of myeloid stem-cell. Typically, an increase of red cell mass and a decrease of erythropoietin is found. In polycythemia vera, augmentation of PCV is frequently associated with elevation of WBC and platelets, as well as splenomegaly. The treatment consists of venosection and administration of P32 or cytostatics; all of which methods exhibit a specific risk. In secondary polycythemias, augmentation of red cell mass is consecutive to increased erythropoietin production; these hypererythropoietinemias may be induced by hypoxia or, rarely, may result from an inappropriate tumoral (malignant or benign) secretion. "Spurious" polycythemias are finally defined by the more or less normal red cell mass. They are divided into three groups: micropolycythemias, relative polycythemias and "spurious" chronic polycythemias. The latter are frequent and exhibit relatively important morbidity and mortality, and therefore the recently proposed new therapeutic approaches should be considered. Tobacco addiction appears to be one of the major causes of these "spurious" polycythemias.

摘要

原发性红细胞增多症源于髓系干细胞的恶性增殖。通常会发现红细胞量增加而促红细胞生成素减少。在真性红细胞增多症中,血细胞比容增加常伴有白细胞和血小板升高以及脾肿大。治疗方法包括静脉放血和给予P32或细胞抑制剂;所有这些方法都有特定风险。在继发性红细胞增多症中,红细胞量增加是促红细胞生成素产生增加的结果;这些红细胞生成素过多症可能由缺氧诱导,或很少情况下由不适当的肿瘤(恶性或良性)分泌引起。“假性”红细胞增多症最终由或多或少正常的红细胞量定义。它们分为三组:微小红细胞增多症、相对性红细胞增多症和“假性”慢性红细胞增多症。后者很常见,且发病率和死亡率相对较高,因此应考虑最近提出的新治疗方法。烟草成瘾似乎是这些“假性”红细胞增多症的主要原因之一。

相似文献

1
[The polycythemias].[红细胞增多症]
Schweiz Med Wochenschr. 1981 Aug 15;111(33):1196-201.
2
"Benign erythrocytosis" and other familial and congenital polycythemias.“良性红细胞增多症”及其他家族性和先天性红细胞增多症。
Eur J Haematol. 1996 Oct;57(4):263-8.
3
The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.骨髓组织学在鉴别早期真性红细胞增多症和继发性(反应性)红细胞增多症中的价值。
Haematologica. 2001 Apr;86(4):368-74.
4
[Secondary polycythemias: the role of erythropoietin].[继发性红细胞增多症:促红细胞生成素的作用]
Rev Med Suisse Romande. 1993 Nov;113(11):865-71.
5
Plasma erythropoietin in health and disease.
Ann Clin Lab Sci. 1980 May-Jun;10(3):250-7.
6
[Behavior and significance of plasmatic erythropoietin in primary and secondary polycythemias].[原发性和继发性红细胞增多症中血浆促红细胞生成素的行为及意义]
Arch Maragliano Patol Clin. 1970 May-Jun;26(3):153-80.
7
Determination of serum erythropoietin. Its value in the differential diagnosis of polycythemias.血清促红细胞生成素的测定。其在红细胞增多症鉴别诊断中的价值。
Nouv Rev Fr Hematol (1978). 1994 Apr;36(2):173-6.
8
[Behavior and significance of plasma erythropoietin in primary and secondary polycythemias].[原发性和继发性红细胞增多症中血浆促红细胞生成素的行为及意义]
Haematologica. 1969;54(11):731-47.
9
Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients.真性红细胞增多症与继发性红细胞增多症。199例患者特征的临床病理评估
Pathol Res Pract. 2001;197(2):77-84. doi: 10.1078/0344-0338-5710013.
10
The differential diagnosis of the polycythemic states.
Ann Clin Lab Sci. 1980 Jul-Aug;10(4):311-9.